3 Things to ask your financial planner before investing
3 Things to ask your financial planner before investing

3 Things to ask your financial planner before investing

Henil Shah Article rating: 5.0

When it comes to investing, it is important to first consult your financial planner before taking any investment decisions. Here are some of the things that you should ask your financial planner before investing.

Glenmark Pharma gets USFDA approval for Clobetasol Propionate Foam
Glenmark Pharma gets USFDA approval for Clobetasol Propionate Foam

Glenmark Pharma gets USFDA approval for Clobetasol Propionate Foam

Apurva Joshi Article rating: 5.0

Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (USFDA) for Clobetasol Propionate Foam, 0.05% (Emulsion Formulation), a generic version of Olux 1‐E Foam, 0.05%, of Mylan Pharmaceuticals Inc.

Coffee Day Enterprises locked at upper circuit
Coffee Day Enterprises locked at upper circuit

Coffee Day Enterprises locked at upper circuit

Geyatee Deshpande Article rating: 3.1

In a meeting of the Executive Committee, Coffee Day Enterprises Limited (CEDL) decided to appoint IDFC Securities as the advisor of the company and its subsidiaries. Reacting to this development the stock of the company surged 5 per cent to hit upper circuit on the BSE.

Infosys, Microsoft collaborate with JG Summit Holdings
Infosys, Microsoft collaborate with JG Summit Holdings

Infosys, Microsoft collaborate with JG Summit Holdings

Pritam Bhawar Article rating: 2.5

Infosys in collaboration with Microsoft, on Monday announced a long-term strategic partnership with JG Summit Holdings, Inc, one of the largest and most diversified conglomerates, headquartered in Manila, Philippines.

Meghmani Organics spiked 10 per cent on Epichlorohydrin project
Meghmani Organics spiked 10 per cent on Epichlorohydrin project

Meghmani Organics spiked 10 per cent on Epichlorohydrin project

Nidhi Jani Article rating: 3.4

The total capex for the said project is amounted to Rs. 275 crore and is likely to generate revenue of around Rs. 460 crore per annum. With commencement of this plant, Meghmani will become first manufacturer of Epichlorohydrin in India which is currently entirely imported to India. This project would further drive the demand for this product, going ahead.


L&T gains on winning major order in Maharashtra
L&T gains on winning major order in Maharashtra

L&T gains on winning major order in Maharashtra

Shohini Nath Article rating: 4.0

The construction arm of Larsen & Toubro (L&T), L&T Construction’s Buildings & Factories business has secured a residential project from City and Industrial Development Corporation of Maharashtra (CIDCO).

NBCC gains 5 per cent on bagging new order
NBCC gains 5 per cent on bagging new order

NBCC gains 5 per cent on bagging new order

Shohini Nath Article rating: 5.0

NBCC has received a Letter of Award (LoA) of work from Indian Institute of Management (IIM) Sambalpur. The shares of the company rose 5.7 per cent intraday on the BSE.


Skipper zooms 17 per cent on new order win
Skipper zooms 17 per cent on new order win

Skipper zooms 17 per cent on new order win

Nidhi Jani Article rating: 5.0

During Q1FY20, the company had secured new orders worth Rs. 185 crores for engineering products from projects related to Power Grid Corporation of India Limited (PGCIL), State Electricity Boards and others. The order book of Skipper, as on June 30, 2019, stood at Rs. 2363 crores which comprises of Exports-17 per cent and Domestic- 83 per cent.

RSS
First30503051305230533055305730583059Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR